Table 4.
Treatment | |||
---|---|---|---|
FP | Other ICS | No ICS | |
Patients with first pneumonia event (%) | |||
Treatment at baseline | 15.5 | 13.8 | 12.7 |
Treatment at last visit before eventa | 12.9 | 10.1 | 8.6 |
First hospitalized pneumonia event (%) | |||
Treatment at baseline | 10.5 | 8.5 | 7.5 |
Treatment at last visit before eventa | 8.3 | 6.6 | 5.2 |
Pneumonia event resulting in death (%) | |||
Treatment at baseline | 0.6 | 1.3 | 1.1 |
Treatment at last visit before eventa | 0.6 | 0.9 | 0.7 |
Abbreviations: FP fluticasone propionate, ICS inhaled corticosteroid. Patients were matched at baseline (matched subgroup by baseline ICS use population, N = 4002). aPercentages are calculated as patients with pneumonia events / patients taking treatment at any time prior to the event or, in those without event, at any time during the study